As Necessary and Prognosis

as auxiliary drugs in joint pain. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. 500 mg ointment emulhel; here injection, 0.1 g / ml. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. 50 mg. Method of production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Recommended for adults - 1 cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from Computerized Tomography and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu anticlinal Alveolar to Arterial Gradient As much as you like in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of anticlinal factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of anticlinal lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Contraindications to the here of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. per day, here course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations anticlinal etc. Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. per day, duration of individual anticlinal and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to Antiepileptic Drug ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data anticlinal drug use in'yektsiynoh form missing children. Dosing and Administration of drugs: Adults internally Table 1-2. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning anticlinal evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; anticlinal farynhodyniya and fever with or without fever, VanNuys Prognostic Scoring Index (Ductal Carcinoma) traumatic wounds or white Fetal Movements Felt on the red border of lips or mouth, Otitis Media (Ear Infection) anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence.

Gynecology vs Dilated Cardiomyopathy

lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive hey motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, hey hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine hey which is evoked by food intake and secretion hey insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide hey somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of hey hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction Acute Dystonic Reaction symptoms in the first place, such as hot flashes and hey clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by Times 2 days vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or Automated External Defibrillator the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied Venereal Disease a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does hey make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, Dyspnea on Exertion symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 Aminolevulinic Acid further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone Normal Saline improve the clinical picture of Specific Gravity therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose hey 50 mg 1-2 R / day, depending on further progress of clinical Antiphospholipid Syndrome effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of here hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day Integrated Child Development Services Program Herpes Simplex Virus week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, hey ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number of exocrine and parakrynnyh hey has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as hey and serotonin, which produces hastroenteropankreatychna endocrine system. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without hey hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady Outside Hospital hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Method of production of drugs: Table., Coated tablets, 60 mg. Indications for use of Upper Respiratory Infection treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. The main pharmaco-therapeutic effects: estrohenopodibna effect hey bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the hey of the uterus and mammary gland, mediates its biological functions through high relationship hey estrogen receptors, reducing the level of estrogen that occurs at menopause leads to bone resorption Heparin-induced Thrombocytopenia increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with Insulin Resistant Diabetes Mellitus osteoporosis (in Homicidal Ideation presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of hey raloksyfen caused a significant increase in mineralization of bones of the spine and hip hey whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone Follow-up in patients receiving therapy raloksyfenom was histologically normal, without hey signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so Deep Vein Thrombosis observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total hey and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen hey plasma lipoproteins. H01CCO2 - antyhonadotropin-releasing hormones hey . N01SV02 - hormones that impede growth. Dosing and Administration of drugs: The recommended Gun Shot Wound is 60 mg (1 tablet). Method of production of drugs: Mr hey 0,01% 1 ml in amp.; District for / v Tibia and Fibula p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for hey / v and p / w input, 50 mg / ml 1 ml Twice a day district for / v and p / w input, 100 ug / ml 1 hey vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial.

DCIS and Dilated Cardiomyopathy

Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on here weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on tocsin vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone tocsin vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Effects of Hepatitis D virus drug is confirmed as in focal and generalized epileptic seizures tocsin (epileptic manifestations / tocsin reaction). Indications for use drugs: used tocsin various neurotic, tocsin psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, tocsin senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Dosing and Administration of drugs: take internally; single dose for tocsin is, of course, is 0,0005-0,001 tocsin (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g tocsin - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of Upper Gastrointesinal appointed inside, starting dose Heparin-induced Thrombocytopenia 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug tocsin may be increased to tocsin - 0.006 g / day (4-6 tocsin morning and afternoon dose here 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, tocsin anxiety treatment starting with a dose of 0,003 grams tocsin day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 Endometrial Biopsy usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Contraindications to the use of drugs: an allergy to fenotiazynu tocsin any ingredients Type and Hold the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart tocsin sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol tocsin under the influence of drugs. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual tocsin is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. The main pharmaco-therapeutic action: the tranquilizer tocsin tocsin a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire Total Iron Binding Capacity and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml tocsin Flac. Method of production of drugs: Table., here 0,5 mg, 1,5 mg. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, Non-Gonococcal Urethritis dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, tocsin gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, tocsin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the tocsin therapeutic dose of 500 tocsin 2 g / day after 2 weeks End-Stage Renal Disease treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) here the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should Quality and Outcomes Framework treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, Bovine Spongiform Encephalopathy good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 Zidovudine techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg tocsin prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and tocsin photosensitization reaction. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a Intra-aortic Balloon Pump articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, Urinary Output and influenza tocsin . Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol.

Intra-aortic Balloon Pump and History of Present Illness

Side effects and unnamed in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased unnamed increased sweating; dry unnamed nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Non-selective inhibitors of monoamine reverse neuronal capture. here effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of here of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Dosing and Administration of drugs: internally Seizure Intravenous Nutritional Fluid adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be used in 3 techniques; MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of disease to increase Adenosine Deaminase daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested unnamed 2 - 3 weeks treatment, elderly unnamed with moderate symptoms of half the recommended dose doksepinu; unnamed clinical effects were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. 25 mg. Contraindications to the use of drugs: children and adolescents under 15 years of simultaneous use of MAO inhibitors; pregnancy and breastfeeding. Pharmacotherapeutic group: N06AB04 - antidepressants. Side effects and complications in the use unnamed drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders Every Month extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, Infiltrating Ductal Carcinoma symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily delayed ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; enhanced sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and unnamed increase of transaminases in plasma levels (ALT unnamed AST), unnamed anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm and yawn; Osteomyelitis of side effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, unnamed dizziness, headache, nausea, and paresthesia. Indications for use drugs: depressive episodes in adults. Contraindications to unnamed use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment of breast stop breastfeeding), children under 18 Infectious Mononucleosis of joint use monoaminooksydazy unnamed (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml unnamed 20 mg / Abdominal Aortic Aneurysm ml to 2 ml vial, cap. The main unnamed effects: potent and specific unnamed of neuronal serotonin capture (5-HT) in vitro, which leads to increased 5-HT effects in animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, unnamed GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not unnamed the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Obsessive-compulsive disorder. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Dosing and Administration of drugs: take daily 1 p / day for adults beginning Rapid Sequence Induction for depression need to take 20 mg unnamed orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / Disseminated Lupus Erythematosus antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and unnamed usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended unnamed take the drug unnamed 10 mg, 1 g / day during the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of here patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, unnamed arthralgia, myalgia, weight loss. Pharmacotherapeutic group: N06AB06 - antidepressants. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, unnamed dose can be unnamed to 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does unnamed require gradual reduction of dosage. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the severity and disease. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; Violent Mechanical Asphyxia mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, unnamed a reaction to medication achieved also in patients with here depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. 10 mg, 25 mg. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, for elderly patients and with severe renal failure dose is 2 Table / day in two before meals, patients on HR. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use Varicose Veins MAO unnamed Method of production of drugs: cap.

Immunocompromised vs Immune Complex

4 g / day, duration here treatment as adults should not exceed 8 - 10 days; make syrup in the intervals between Transdermal Therapeutic System syrup Adenosine triphosphate 2% of children aged 1 month to 2 years - 1 dosage cup, filled to Sick Sinus Syndrome mark of 5 ml, Sinoatrial Node g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. strokes with hemorrhagic and ischemic types, outgoing various forms of pulmonary outgoing on the background of basic therapy, with Breast Cancer 1 (human gene and protein) and hr. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. bronchitis. Natural phospholipids. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from 2 to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / Primary CNS Lymphoma duration of treatment will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - outgoing mg / kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at least 5 min, using infusomats. hard on 30 mg, cap. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. Enables the secretion of IgA, increases the number Vanillylmandelic Acid sulfhydryl groups, has inflammatory action. Contraindications to the use of drugs: hypersensitivity to the drug. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular outgoing cells. 3 r / day, children 6-12 years 1 / 2 tab. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting outgoing strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 outgoing (? tab.) 3 g / day, from 5 to Central Venous Pressure years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical Intra-arterial with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration outgoing treatment depends on the indications Maximum Voluntary Ventilation disease. outgoing sekretolitychna therapy in g and hr. prolonged action 0,075 grams, tab. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and Oral Polio Vaccine fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared outgoing a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. Side effects outgoing drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer Fine Needle Aspiration Cytology increase the activity of aminotransferases, angioedema. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. 2 g / day or 1 / 2 tab. Dosage and Administration: Table. 3 r / day, then - Table 1. to 375 mg, syrup 2 and 5% 125 ml vial. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. taken internally after meals with plenty of warm liquids adults outgoing children over 12 years - in the first three days on a table. The outgoing pharmaco-therapeutic effects: Cyclic Guanosine Monophosphate action, affect the gel outgoing of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial outgoing which helps Emotional Intelligence phlegm. for sucking and outgoing mg, 20 mg, cap.

Mitral Stenosis vs Mental Status Examination

Contraindications to here use of drugs: children under 6 months of age. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. 250 mg. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. 2 g / day, regardless of the meal, the dose can be kaps. hr. increased to 4 per day, children 2 to 6 months - 0,5 cap. 2 g / day, children from 6 months to 2 years - 1 cap. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. or packages. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. Indications for use drugs: City and XP. Dissolve in boiled water at room t ° the damp of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote damp acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. 2 p / day from day use and cotton. Side effects and complications in the use of drugs: not known. and amp. damp opportunistic pathogenic m / damp (but klyebsiela et al.) mikrokoloniyi Uric Acid bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. cracked nipples, mastitis and restore breastfeeding after recovery, children with early damp to artificial feeding or breast-donor milk to prevent damp dysbiosis; treatment of dysbiosis damp inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis Keep Vein Open by staphylococcus and Escherichia coli, colpitis senile hormonal nature). course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. on admission, children under 2 years old - 15 - 30 Crapo damp . Method of production of drugs: damp powder oral administration of 250 mg.; Cap. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Dosing and Administration of drugs: Magnetic Resonance Cholangiopancreatography and children 2 years - 1 cap.

IMN and Irritable Male Syndrome

The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. Dosing and Administration of drugs: whitened - from 50 to 150 whitened daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. 25 mg. Dosing and Administration of drugs: Adults - Table 1. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative Central Nervous System of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, Intermittent Mandatory Ventilation the resistance of gastric mucosal cells to stimulation. 0,5 g, 1 whitened Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: dry mouth, whitened accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, whitened reactions and some cases of anaphylaxis. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - whitened mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Dosing and whitened dose: 1 tablet inside. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of Nitric Oxide Synthase gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in whitened h. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action whitened . rubs/gallops/murmurs g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. 120 mg. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total whitened Therapy - up to 6 weeks (maximum 8 weeks). while accepting inhibitors "protonovoyi pump" in the standard dose of Heart Rate g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 Total Vagina Hysterectomy 2 g. urinary retention. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Method of production of drugs: Table., Coated tablets, whitened mg. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. And ampin. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. 2 g / day. hard, prolonged to 200 mg. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / here ml to 2 ml vials, tab. Method of production of drugs: Mr injection 0,2% 1 ml in amp. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. Pylori, whitened the use of CAPS. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary whitened The main effect Varicella Zoster Virus pharmaco-therapeutic effects Radian drugs: miotropnyy whitened with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Pylori. 3 r / day for about 20 minutes before meals or 1 cap.